-
公开(公告)号:US12037407B2
公开(公告)日:2024-07-16
申请号:US18311856
申请日:2023-05-03
发明人: Jasper Williams , Michelle Nguyen , Anzhi Yao , Stephen Santoro , Aaron Cooper , John Gagnon , Adam Litterman , Omar Khan , Natalie Bezman , Katherine Harris , Harbani Kaur Malik Chaudhry , Nicole Allen
CPC分类号: C07K16/2878 , A61P35/00 , C07K16/2896 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
-
公开(公告)号:US20230340139A1
公开(公告)日:2023-10-26
申请号:US18311856
申请日:2023-05-03
发明人: Jasper Williams , Michelle Nguyen , Anzhi Yao , Stephen Santoro , Aaron Cooper , John Gagnon , Adam Litterman , Omar Khan , Natalie Bezman , Katherine Harris , Harbani Kaur Malik Chaudhry , Nicole Allen
CPC分类号: C07K16/2878 , C07K16/2896 , A61P35/00 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
-
公开(公告)号:US20230192843A1
公开(公告)日:2023-06-22
申请号:US18046213
申请日:2022-10-13
CPC分类号: C07K16/28 , A61P35/00 , C07K16/2809 , A61K39/00 , C07K2317/31 , C07K2317/622
摘要: Single domain antibodies which specifically bind to mesothelin (MSLN) and mesothelin binding proteins, anti-mesothelin antibodies and antibody fragments thereof, antibody-drug conjugates, synthetic immune receptors, and diagnostic agents comprising the same are disclosed. Also disclosed are pharmaceutical compositions comprising any of the foregoing and uses of any of the foregoing in the treatment and/or diagnosis and/or monitoring of a disease associated with MSLN expression.
-
公开(公告)号:US20240309106A1
公开(公告)日:2024-09-19
申请号:US18677547
申请日:2024-05-29
发明人: Jasper Williams , Michelle Nguyen , Anzhi Yao , Stephen Santoro , Aaron Cooper , John Gagnon , Adam Litterman , Omar Khan , Natalie Bezman , Katherine Harris , Harbani Kaur Malik Chaudhry , Nicole Allen
CPC分类号: C07K16/2878 , A61P35/00 , C07K16/2896 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
-
公开(公告)号:US20230365997A1
公开(公告)日:2023-11-16
申请号:US18308481
申请日:2023-04-27
发明人: Aaron Cooper , Angela Boroughs , Pei-Ken Hsu
CPC分类号: C12N15/907 , A61K39/4611 , A61K39/4631 , A61P35/00 , C12N9/22 , C12N15/11 , C12N2310/20 , C12N2800/80
摘要: Provided herein are compositions and methods for producing genomically edited cells expressing an exogenous transgene and restored or continued expression of an endogenous gene. Methods of using the genomically edited cells for treating or preventing a disease in a subject are also provided.
-
公开(公告)号:US11761004B2
公开(公告)日:2023-09-19
申请号:US17716816
申请日:2022-04-08
发明人: Xinying Zheng , Brendan Galvin , Somya Khare , Aaron Cooper , Michelle Nguyen , Anzhi Yao
IPC分类号: C12N15/113 , A61K35/17 , C12N5/0783 , C12N15/11 , C12N9/22 , C12N15/85
CPC分类号: C12N15/1136 , A61K35/17 , C12N5/0636 , C12N9/22 , C12N15/111 , C12N15/85 , C12N2310/20
摘要: Provided herein are safe harbor loci and methods for identifying and using safe harbor loci to engineer cells to express transgenes. The safe harbor loci exhibit increased transgene knock-in efficiency and allow for increased, stable expression of transgenes in engineered cells. Guide ribonucleic acids (gRNAs) may be used for insertion of transgenes in the safe harbor loci.
-
公开(公告)号:US20220235380A1
公开(公告)日:2022-07-28
申请号:US17689837
申请日:2022-03-08
发明人: Jasper Williams , Michelle Nguyen , Anzhi Yao , Stephen Santoro , Aaron Cooper , John Gagnon , Adam Litterman , Omar Khan , Natalie Bezman
IPC分类号: C12N15/90 , C07K14/725 , C07K14/705 , C12N9/22 , C12N15/85 , A61P35/00
摘要: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
-
公开(公告)号:US20220127616A1
公开(公告)日:2022-04-28
申请号:US17239484
申请日:2021-04-23
发明人: Xinying Zheng , Brendan Galvin , Somya Khare , Aaron Cooper , Michelle Nguyen , Anzhi Yao
IPC分类号: C12N15/113 , A61K35/17 , C12N5/0783 , C12N15/85 , C12N15/11 , C12N9/22
摘要: Provided herein are safe harbor loci and methods for identifying and using safe harbor loci to engineer cells to express transgenes. The safe harbor loci exhibit increased transgene knock-in efficiency and allow for increased, stable expression of transgenes in engineered cells. Guide ribonucleic acids (gRNAs) may be used for insertion of transgenes in the safe harbor loci.
-
公开(公告)号:US20240342284A1
公开(公告)日:2024-10-17
申请号:US18593711
申请日:2024-03-01
发明人: Angela Boroughs , Levi Gray-Rupp , Samuel A. Williams , Zhen Jian Zhou , Matthew Drever , Duy Nguyen , Amy-Jo Casbon , Anzhi Yao , Thomas Gardner
IPC分类号: A61K39/00 , A61P35/00 , C07K14/725 , C07K16/30 , C07K16/40 , C12N9/22 , C12N15/11 , C12N15/90
CPC分类号: A61K39/464495 , A61K39/4631 , A61K39/464454 , A61P35/00 , C07K14/7051 , C07K16/3069 , C07K16/40 , C12N9/22 , C12N15/11 , C12N15/907 , C07K2317/31 , C12N2310/20
摘要: Provided herein are antibodies and chimeric priming receptors that bind PSMA and antibodies and chimeric antigen receptors that bind CA9. Also provided are systems of chimeric priming receptors that bind PSMA and chimeric antigen receptors that bind CA9, cells expressing such systems, and methods of use thereof.
-
公开(公告)号:US20240240164A1
公开(公告)日:2024-07-18
申请号:US18379912
申请日:2023-10-13
发明人: Aaron Cooper , Pei-Ken Hsu , Robert Moot , Annie Truong , Thomas Gardner , Brian Hsu
CPC分类号: C12N9/22 , C12N15/11 , C12N15/907 , C12N2310/20 , C12N2800/80
摘要: Provided herein are compositions and methods for producing genetically engineered cells, such as T cells, with an insertion of a cassette at a designated genomic locus. Methods of using the genetically engineered cells for treating or preventing a disease in a subject are also provided.
-
-
-
-
-
-
-
-
-